Investigating two mobile just-in-time adaptive interventions to foster psychological resilience: research protocol of the DynaM-INT study

Bögemann, S. A.; Riepenhausen, A.; Puhlmann, L. M. C.; Bar, S.; Hermsen, E. J. C.; Mituniewicz, J.; Reppmann, Z. C.; Uściƚko, A.; van Leeuwen, J. M. C.; Wackerhagen, C.; Yuen, K. S. L.; Zerban, M.; Weermeijer, J.; Marciniak, M. A.; Mor, N.; van Kraaij, A.; Köber, G.; Pooseh, S.; Koval, P.; Arias-Vásquez, A.; Binder, H.; De Raedt, W.; Kleim, B.; Myin-Germeys, I.; Roelofs, K.; Timmer, J.; Tüscher, O.; Hendler, T.; Kobylińska, D.; Veer, I. M.; Kalisch, R.; Hermans, E. J.; Walter, H.

doi:10.1186/s40359-023-01249-5

Table 2 List of inclusion criteria and format in which they were assessed

From: Investigating two mobile just-in-time adaptive interventions to foster psychological resilience: research protocol of the DynaM-INT study

Nr	Criterion	Format
1	Age between 18 and 27	Online
2	3 or more life events rated as burdening [27]	Online
3	GHQ-28 score of 20 or higher [28]	Online
4	Body mass index between 18 and 27	Online
5	Currently studying or in vocational training	Online
6	Proficiency in the official language of the country of study enrollment (minimum level of C1 in the Common European Framework of Reference for Languages)	Online
7	Eligibility to participate in ecological physiological assessment using a wearable device (no skin disease in the wrist or chest area and no medical condition that increases risk of infection through electrodes, no medication with phototoxic side effects)	Online
8	The participant has a smartphone with iOS or Android operating system	Online
9	No lifetime diagnosis of any severe mental or organic disorder that affects neurodevelopment due to its pathological mechanism or treatment (e.g., schizophrenia, bipolar disorder, anorexia/bulimia nervosa, attention deficit hyperactivity disorder, autism spectrum disorder, meningitis, epilepsy, multiple sclerosis, stroke, brain cancer, brain concussion, or coma)	Online + interview
10	Eligibility for undergoing the functional magnetic resonance imaging protocol (normal or corrected-to-normal eyesight, no hearing impairment, no claustrophobia, no non-removable ferromagnetic metal in or at the body, not pregnant, no large tattoo in head or neck area)	Online + interview
11	No diagnosis within 9 months before inclusion of any mental disorder other than a mild depressive episode (ICD F32.1), tobacco abuse/dependence (ICD F12), or substance abuse, as assessed using the Mini-International Neuropsychiatric Interview (M.I.N.I.)[36]	Interview
12	The participant has not participated in the previous DynaM-OBS study or any study using an EMI similar to ReApp or Imager	Interview
13	No consumption of any psychoactive drug or substance up to 4 weeks prior to the first psychological assessment and to the MRI assessment	Drug test
14	The participant has received all relevant information about the study, is able to obtain full insight and is fully contractually capable, is willing and able to comply with the protocol and agrees to participate by giving written consent	Interview

Participants who are found eligible in criteria 1–10 in the anonymous online screening are invited to a phone interview (on-site interview in Mainz and Nijmegen) to confirm/check eligibility for criteria 9–12. During their first in-person appointment, participants receive written and verbal information about the study and provide written informed consent (criterion 14). Inclusion criterion 10 only applies to the MRI subsample: participants who are not eligible for undergoing the MRI procedure skip the neuroimaging procedures and take part in all other parts of the study. During the baseline day (both baseline days in the case of Mainz and Nijmegen see Fig. 1), a drug test is performed

Back to article page

ISSN: 2050-7283

Contact us

General enquiries: journalsubmissions@springernature.com

BMC Psychology

Contact us